▮ More

NOV Inc. Q3 Earnings Summary

By RTTNews Staff Writer ✉ | Published: 10/27/2022 5:17 PM ET

Below are the earnings highlights for NOV Inc. (NOV):

Earnings: $32 million in Q3 vs. -$69 million in the same period last year.
EPS: $0.08 in Q3 vs. -$0.18 in the same period last year.
Revenue: $1.89 billion in Q3 vs. $1.34 billion in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Biotech stocks Facing FDA Decision in January 2023

Biotech Stocks Facing FDA Decision In December 2022

Biotech Stocks Facing FDA Decision In November 2022

Latest Updates on COVID-19

U.S. Covid Metrics Signal Ease In Pandemic

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

US Covid Deaths Rise By 78% In 2 Weeks

78% Increase In US Covid Deaths In A Fortnight

Pentagon Repeals Memo Mandating Covid Vaccination For Armed Forces

COVID-19: Drugs in Development

Follow RTT

Editor's Pick
Most Read
Most Emailed

Chevron Q4 Profit Up 25%, But Misses Estimates

ZLINE Expands Recall Of Gas Ranges

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

Drizzilicious Mini Rice Cake Bites, Popcorn Recalled

Comcast Q4 Profit Edges Down, But Results Top Estimates

Meta To Reinstate Donald Trump's Facebook, Instagram Accounts

NOV Inc. Q3 Earnings Summary

Chevron Q4 Profit Up 25%, But Misses Estimates

ZLINE Expands Recall Of Gas Ranges

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

Drizzilicious Mini Rice Cake Bites, Popcorn Recalled

Comcast Q4 Profit Edges Down, But Results Top Estimates

Meta To Reinstate Donald Trump's Facebook, Instagram Accounts

Almondy Chocolate Cake With Daim Recalled

Amazon Workers At UK Warehouse On Strike

Boeing Q4 Loss Sharply Narrows; Results Miss Estimates

AT&T Slips To Loss On Charges, But Adj. EPS Tops View

ASML Q4 Profit Up, Bookings Down; Sees Growth In FY23

FDA Bans 2 Vuse Menthol E-cigarette Products

Johnson & Johnson Q4 Profit Down 26%, But Adj. EPS Tops Estimates

SkinnyDipped Dark Chocolate Nut Products Recalled

Sandoz To Acquire Antifungal Agent Mycamine From Astellas Pharma

Cidara: FDA Committee Recommends FDA Approve Rezafungin For Candidemia, Invasive Candidiasis

Kura Oncology Announces FDA Clearance For IND Application For KO-2806

Emerson Says Committed To Proceed With National Instruments' Acquisition

Altamira: NASAR Interim Analysis Shows Superior Efficacy Of Bentrio In Seasonal Allergic Rhinitis

Intuitive Surgical Inc. Q4 Profit Decreases, misses estimates

Cognizant To Buy UK's Mobica To Boost IoT Services

Syros Gets Fast Track Designation In U.S. For Tamibarotene For Myelodysplastic Syndrome Treatment

Lonza FY22 Profit Up, Lifts Dividend; Sees Higher FY23 Sales, Weak Margin; Plans CHF 2 Bln Buyback

Abbott Issues FY23 Earnings, Sales Growth View - Update

Swatch Group FY22 Profit Rises; Sees Strong Growth In FY23

American Airlines Group Q4 Profit Tops Estimates; Achieves Record Revenue

OSI Systems Q2 Profit Down, But Above Estimates - Update

Superdry Posts Wider Adj. Pretax Loss In H1, Revenue Up 3.6%; Revises Outlook

Volvo Group Q4 Adj. Operating Profit Rises; Adj. Net Sales Up 17%

Wetherspoon 25-week LFL Sales Up 13.1%; Cautiously Optimistic About FY Prospects

Abbott Issues FY23 Earnings, Sales Growth View - Update

Automatic Data Processing Inc. Q2 Profit Increases, beats estimates

KLA Corporation Q2 Profit Increases, beats estimates

Norfolk Southern Corp Q4 Profit Rises, but misses estimates

HighPeak Energy Seeks Strategic Alternatives, Stock Up 7%

Cognizant To Buy UK's Mobica To Boost IoT Services